Third Quarter 2025 Financial Results © 2025 Moderna, Inc. All rights reserved. Forward-looking statements and disclaimer November 6, 2025 This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: Moderna's ability to drive use of Spikevax, mNEXSPIKE and mRESVIA; Moderna's strategic global partnerships; Moderna's ability to advance its pipeline to drive sales growth; Moderna's 2025 financial fr ...